Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.

Abstract

BACKGROUND Panic disorder is a common and disabling condition which can be treated with selective serotonin reuptake inhibitors (SSRIs). Although many subjects respond well to such treatment, there is substantial inter-individual variation implicating genetic factors. METHODS 102 patients with a diagnosis of panic disorder receiving sertraline or… (More)
DOI: 10.1016/j.jad.2009.09.007

Topics

  • Presentations referencing similar topics